CHINA DONGXIANG (03818) Cancels 256 Million Repurchased Shares
CHINA DONGXIANG (03818) announced that on November 4, 2026, the company cancelled 256 million repurchased shares.
CHINA DONGXIANG (03818) announced that on November 4, 2026, the company cancelled 256 million repurchased shares.
Related Articles
Muyuan Foods Group (02714) repurchased 65,700 shares on November 4 for HK$2.5189 million.
Shanghai Fosun Pharmaceutical (02196): Phase III clinical trial of FXS6837 capsules for the treatment of paroxysmal nocturnal hemoglobinuria initiated in China
TONGRENTANGCARE (02667) received an increase of 100,000 shares by a company executive.
Muyuan Foods Group (02714) repurchased 65,700 shares on November 4 for HK$2.5189 million.
Shanghai Fosun Pharmaceutical (02196): Phase III clinical trial of FXS6837 capsules for the treatment of paroxysmal nocturnal hemoglobinuria initiated in China
TONGRENTANGCARE (02667) received an increase of 100,000 shares by a company executive.
